Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
- 1 August 1988
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 85 (15), 5678-5682
- https://doi.org/10.1073/pnas.85.15.5678
Abstract
Paramyosin (Sm97), a 97-kDa myofibrillar protein identified by the unusually monospecific antibody response induced by intradermal vaccination of mice with a comples soluble worn antigen preparation (SWAP) of adult Schistosoma mansoni administered with bacillus Calmette-Guerin (BCG), was purified and tested for its capacity to protect mice against challenge infection. When administered intradermally with BCG at total doses of only 4-40 .mu.g per mouse, both the native molecule and a recombinant expression product containing approximately 50% of the whole protein were found to confer significant resistance (26-33%) against challenge infection, while 2 mg of unfractionated SWAP was required to induce similar levels of protection. In addition, parmyosin was shown to stimulate T lymphocytes from vaccinated mice to produce lymphokines [e.g., .gamma. interferon [IFN-.gamma.)] that activate macrophages to kill schistosomula. Neither schistosome myosin for a heterologous paramyosin from a different invertebrate genus were protective, indicating a requirement for specific epitopes in the immunization. That the protection induced by paramyosin involves a T-cell-mediated mechanism was supported by the failure of antiparamyosin antibodies to passively transfer significant resistance to infection to recipient mice. Lymphocytes from mice vaccinated with paramyosin were found to produce IFN-.gamma. in response to living schistosomula, suggesting that during challenge infection of vaccinated hosts, paramyosin (a nonsurface antigen) many elicit a protective T-cell response as a consequence of its release from migrating parasite larvae. Paramyosin-depleted SWAP was also found to be protective as well as stimulatory for T lymphocytes from SWAP-vaccinated mice, indicating that other antigens in this preparation may have immunoprophylactic potential. In summary, these results (i) suggest that the induction of T-cell-dependent cell-mediated immunity against soluble nonsurface antigens may be an effective strategy for immunization against multicellular parasites and (ii) in the case of schistonsomes, identify paramyosin as a candidate vaccine immunogen in this category.This publication has 21 references indexed in Scilit:
- Induction of protective immunity against Schistosoma mansoni by a non‐living vaccine. VI. Antigen recognition by non‐responder mouse strainsParasite Immunology, 1988
- Immunity to Schistosomes: Progress Toward VaccineScience, 1987
- A sensitive immunochemical assay for biologically active MuIFN-γJournal of Immunological Methods, 1987
- Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. V. Effects of varying the immunization and infection schedule and siteParasite Immunology, 1987
- Identification of Paramyosin as Schistosome Antigen Recognized by Intradermally Vaccinated MiceScience, 1986
- Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivoParasite Immunology, 1986
- Ultrastructural studies of the killing of schistosomula of Schistosoma mansoni by activated macrophages in vitroParasite Immunology, 1985
- Schistosoma mansoni: Rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of PercollExperimental Parasitology, 1982
- In vitroproliferative response to living schistosomula by T lymphocytes from mice infected withSchistosoma mansoniParasitology, 1981
- Myosin and paramyosin of Caenorhabditis elegans: Biochemical and structural properties of wild-type and mutant proteinsCell, 1977